MORE THAN A MAGAZINE, A MOVEMENT [[link removed]]
Today at Ms. | January 21, 2026

With Today at Ms. —a daily newsletter from the team here at Ms. magazine—our top stories are delivered straight to your inbox every afternoon, so you’ll be informed and ready to fight back.

I Grew Up Wanting to Be Ruth Bader Ginsburg. I’m Coming of Age Under Trump. [[link removed]]
(Spencer Platt / Getty Images)

By Hazel Kaminsky | I have aspired for a political career since elementary school, where I would pour over books about female trailblazers. As a fifth grader, I dressed up as Ruth Bader Ginsburg for Halloween and posed for a photo with a boy my age dressed in a Trump costume.

I am a high school senior now, and the playful divide that picture symbolized has become all too real.

As Jan. 20 approaches—the one-year anniversary of Donald Trump’s inauguration—I find myself taking stock of what has shifted in that first year of his return to power. The political climate that once felt abstract or distant now shapes my classrooms, my friendships and my sense of what adulthood will demand of me.

(Click here to read more) [[link removed]]

Keeping Score: Renee Good Fatally Shot by ICE; Women Work Longer and Are Paid Less Worldwide; N.Y. Fights Back Against Federal Childcare Freeze [[link removed]]
(Instagram; Anna Moneymaker / Getty Images; Stephen Maturen / Getty Images)

By Katie Fleischer | In every issue of Ms. , we track research on our progress in the fight for equality, catalogue can’t-miss quotes from feminist voices and keep tabs on the feminist movement’s many milestones. We’re Keeping Score [[link removed]] online, too—in this biweekly roundup.

(Click here to read more) [[link removed]]

‘The Moral Property of Women’: Mifepristone, Fibroids and the Stakes of Suppressed Science [[link removed]]
(Art by Brandi Phipps)

By Carrie N. Baker | On Sept. 28, 2025, activists nationwide commemorated the 25th anniversary of the U.S. Food and Drug Administration’s approval of mifepristone for early termination of pregnancy.

Beyond abortion care, the FDA has also approved mifepristone for treatment of Cushing’s disease (a hormonal disorder) and has granted “compassionate use” to treat meningioma (a benign brain tumor) and other serious or immediately life-threatening conditions. Doctors widely prescribe mifepristone off-label to manage miscarriage, treat ectopic pregnancies, support cervical dilation during childbirth and induce labor.

But the drug has many other uses, especially for women.

(Click here to read more) [[link removed]]

[link removed] [[link removed]]
Tune in for a new episode of Ms. magazine's podcast, On the Issues with Michele Goodwin, at MsMagazine.com, [[link removed]] Apple Podcasts [[link removed]] or wherever you listen to podcasts.

Welcome to “The Magazine,” our mini-pod, which gives a peek into Ms . magazine’s forthcoming and current issues. In this episode, take a glimpse inside our Winter 2026 issue, which delves into the promise and potential of the abortion medication Mifepristone—which has been shown to treat a striking range of diseases and conditions including fibroids, breast cancer, depression, endometriosis and more. Also in the Winter issue: Jess Michaels on surviving Epstein, the Iceland “Women’s Strike” turns 50, and more.
We hope you'll listen, subscribe, rate and review today!
[link removed] [[link removed]]

READ THE REST [[link removed]] | GET THE MAGAZINE [[link removed]] | SUPPORT MS. [[link removed]]

[link removed] [[link removed]] [link removed] [[link removed]] [link removed] [[link removed]]

Enjoy this newsletter? Forward to a friend!
Was this email forwarded to you by a friend? Subscribe [[link removed]] .


Ms. Magazine
1600 Wilson Boulevard
Suite 801
Arlington, VA 22209
United States
Manage your email subscriptions here [[link removed]]
If you believe you received this message in error or wish to no longer receive email from us, please
unsubscribe: [link removed] .